Novel strategies for the treatment of heart failure

Izhak Kehat1

  • 1The Clinical Research Institute at Rambam (CRIR), the Heart Institute, Rambam Medical Center, Haifa, Israel and the Department of Physiology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Insights

New heart failure therapies target cellular and molecular remodeling. These emerging treatments aim to reverse cardiac dysfunction by addressing abnormalities at multiple levels for future clinical use.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pharmacology

Background:

  • Heart failure is a growing global health concern, leading to significant morbidity and mortality.
  • Current treatments primarily focus on neurohumoral inhibition and managing fluid overload with diuretics.
  • Pathophysiological understanding reveals that cardiac remodeling at cellular and molecular levels drives heart failure progression.

Purpose of the Study:

  • To discuss emerging therapeutic strategies for heart failure.
  • To highlight novel approaches targeting cellular and molecular remodeling processes.
  • To explore interventions addressing receptor function, calcium handling, and extracellular matrix changes.

Main Methods:

  • Review of experimental strategies for heart failure treatment.
  • Discussion of interventions aimed at correcting cellular and molecular abnormalities.
  • Analysis of approaches targeting signaling pathways and excitation-contraction coupling.

Main Results:

  • Identification of multiple levels for therapeutic intervention in heart failure.
  • Focus on correcting receptor and post-receptor dysfunction.
  • Exploration of strategies to modify calcium handling and extracellular matrix.

Conclusions:

  • Emerging therapies offer a new paradigm for heart failure treatment by targeting remodeling.
  • Novel approaches aim to reverse cardiac dysfunction at cellular and molecular levels.
  • These innovative strategies hold promise for future clinical application in managing heart failure.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...